U.S. Food and Drug Administration has approved Novartis' gene therapy for a type of rare muscle disorder, the drugmaker said ...
Spinal motor neurons are specified to innervate different muscle targets through combinatorial programs of transcription factor expression. Whether transcriptional programs also establish finer ...
A drug candidate found to protect nerve cells damaged by motor neuron disease (MND), could offer new hope to people living ...
The molecular and cellular basis of selective motor neuron (MN) vulnerability in amyotrophic lateral sclerosis (ALS) is not known. In genetically distinct mouse models of familial ALS expressing ...
ALS is short for amyotrophic lateral sclerosis, which is also known as Lou Gehrig's disease. ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results